article thumbnail

STAT+: Lawmaker accuses Amgen of placing profits above patients with dosing for a cancer drug

STAT

At the time, the Food and Drug Administration required Amgen to run a trial confirming earlier test results, as well as a so-called post-marketing study to examine safety and effectiveness at different dosages, in order to gain full approval. Continue to STAT+ to read the full story…

Dosage 139
article thumbnail

Eliquis generic availability, cost, and dosage

The Checkup by Singlecare

Although a generic was approved in 2019, generic apixaban will not be available on the market until at least April 2028. Summary A generic version of Eliquis may not be available until at least April 2028. The post Eliquis generic availability, cost, and dosage appeared first on The Checkup. What is Eliquis used for?

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Handling HPAPIs safely – what does it take?

European Pharmaceutical Review

Based on the latest report and data, HPAPI market size is expected to reach $32 billion by 2028. With a career spanning over 20 years, Dr Hotha has extensive expertise in developing drug substances and products, particularly in HPAPI, Drug linkers, ADCs, and complex drug dosage forms.

article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

Subject to planning permission, the site is expected to be opened by 2028. A €25 million drug delivery manufacturing investment To boost capacity in producing user-friendly oral dosage forms, German CDMO HERMES Pharma announced in September it is investing €25 million in its manufacturing capabilities.

Vaccines 104
article thumbnail

CMS Rolls up its Sleeves on Price Negotiations, Sets Agenda for 2026 Negotiated Prices

The FDA Law Blog

The topics focus on issues relevant in the first three years of the Negotiation Program—2026 to 2028. Method for applying the MFP across different dosage forms and strengths of a selected drug. Upcoming CMS Guidance CMS provides a list of topics on which it plans to issue guidance.

Dosage 59
article thumbnail

Compliance to convenience: understanding the latest innovations in capsule formulation

Pharmaceutical Technology

According to the World Health Organisation, the simplicity of a dosage regimen is one of the factors with the greatest influence on therapy adherence[1]. The softgel capsule can contain a second solid dosage form, in softgel, tablet or granule form, enabling multi-active formulations for unique prescription, OTC and nutraceutical products.

Dosage 52
article thumbnail

PROTAC development gains momentum, but clinical performance is poor

Pharmaceutical Technology

This makes early R&D less risky, as many lead compounds are discontinued due to inadequate pharmacokinetic profiles and require excessively high dosages to be pharmaceutically active. GlobalData’s analyst consensus forecast database estimates peak annual sales for ARV-110 of $325 million in 2028.